Vogenx Inc (VOGX)
VOGX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | VOGX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0001903784 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. "Accordingly, management concluded that substantial doubt regarding the Company's ability to continue as a going concern does not exist. 5 Table of Contents Reverse stock split On July 21, 2026 the Company's board of directors approved a one-for-three reverse stock split, which was effected on July 28, 2026, of the Company's issued and outstanding shares of common stock." | 10-Q 2026-11-06 |
| Cash and burn | $5.1M cash; operating cash flow -$1.4M a quarter. | Report 2026-09-30 |
| Shares outstanding | 14,855,087 (2026-11-05). | Cover page 2026-11-05 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | BDO USA, P.C., Raleigh, North Carolina, United States | PCAOB Form AP 2026-08-04 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | Not filed | -$4.9M | -$2.6M | $5.1M | $0 | Needs four quarters | 10-Q 2026-11-06 |
| Q3 2026 2026-06-30 | Not filed | -$384K | Not filed | $193K | $868K | Needs four quarters | 10-Q 2026-11-06 |
| Q3 2026 2026-03-31 | Not filed | -$475K | Not filed | Not filed | No debt tags | Needs four quarters | 10-Q 2026-11-06 |
| Q3 2026 2025-09-30 | Not filed | -$284K | -$156K | $234K | No debt tags | Needs four quarters | 10-Q 2026-11-06 |
| Q3 2026 2025-06-30 | Not filed | -$295K | Not filed | $390K | No debt tags | Needs four quarters | 10-Q 2026-11-06 |
| Q3 2026 2025-03-31 | Not filed | -$357K | Not filed | Not filed | No debt tags | Needs four quarters | 10-Q 2026-11-06 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B4 | 424B4 | 2026-08-12 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-06 |
| Latest current report FORM 8-K | 8-K | 2026-11-06 |
Source: SEC EDGAR submissions feed, 43 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.5% |
| 1 month | -0.5% |
| 3 months | +18.3% |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -51.2% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ACIU | AC Immune SA | $2.09 | -1.88% | $212.7M |
| YARW | Yarrow Bioscience Inc. | $13.93 | -22.74% | $212.2M |
| CYPH | Cypherpunk Technologies Inc. | $1.93 | +2.94% | $207.4M |
| DRUG | Bright Minds Biosciences Inc. | $22.61 | -2.16% | $222.0M |
| SIGA | SIGA Technologies Inc. | $2.85 | +4.01% | $204.8M |
| BCYC | Bicycle Therapeutics plc | $3.18 | -5.64% | $222.9M |
| GLSI | Greenwich LifeSciences Inc. | $13.76 | -7.90% | $202.0M |
| IMRX | Immuneering Corporation | $3.52 | -5.12% | $228.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier